FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1783-1785 June 29, 1995 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Leukemia can be acute or chronic, derive from different types of cells, and arise by different mechanisms, most of which are still unknown. One unique form — adult T-cell leukemia–lymphoma — though rare in many geographic regions, is common in others. It is perhaps the most thoroughly studied type of leukemia. We know more about its distribution, cause, and pathogenesis than we do about those of other leukemias,^1,2,3,4,5,6 but paradoxically, it remains one of the most difficult cancers to treat.⁴ Two reports in this issue of the Journal may herald a change in that situation.^7,8

In 1977 Takatsuki and his . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Tobinai, K., Kobayashi, Y., Shimoyama, M., The Lymphoma Study Group of the Japan Clinical Onc, , Pagano, J. S., Gill, P. S., Harrington, W., Levine, A. M. (1995). Interferon Alfa and Zidovudine in Adult T-Cell Leukemia-Lymphoma. NEJM 333: 1285-1286 [Full Text]